TrialThe Journal of infectious diseases2024

Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo.

Ynke Larivière et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.